Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing

PURPOSE: Gallbladder sarcomatoid carcinoma is a rare cancer with no clinical standard treatment. With the rapid development of next generation sequencing, it has been able to provide reasonable treatment options for patients based on genetic variations. However, most cancer drugs are not approval fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Feiling, Cheng, Qingbao, Yang, Liang, Zhang, Dadong, Ji, Shunlong, Zhang, Qiangzu, Lin, Yihui, Li, Fugen, Xiong, Lei, Liu, Chen, Jiang, Xiaoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354913/
https://www.ncbi.nlm.nih.gov/pubmed/28029662
http://dx.doi.org/10.18632/oncotarget.14146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354913/
https://www.ncbi.nlm.nih.gov/pubmed/28029662
http://dx.doi.org/10.18632/oncotarget.14146

Ejemplares similares